Brugada syndrome: A heterogeneous disease with a common ECG phenotype?

Journal of Cardiovascular Electrophysiology

Volumn 25, Issue 4, 2014, Pages 450-456

  Gray, Belinda ^a,b,c   Semsarian, Christopher ^a,b,c   Sy, Raymond W ^a,c  

^a ROYAL PRINCE ALFRED HOSPITAL   (Australia)

^b CENTENARY INSTITUTE   (Australia)

^c UNIVERSITY OF SYDNEY   (Australia)

Author keywords

arrhythmogenic right ventricular cardiomyopathy; Brugada syndrome; genetics; heterogeneity; sodium channel; substrate

Indexed keywords

CALCIUM CHANNEL; GAP JUNCTION PROTEIN; POTASSIUM CHANNEL; SODIUM CHANNEL;

BRUGADA SYNDROME; CARDIOVASCULAR MAGNETIC RESONANCE; CATHETER ABLATION; ELECTROCARDIOGRAM; FAMILY HISTORY; HEART DEPOLARIZATION; HEART REPOLARIZATION; HEART RIGHT VENTRICLE DYSPLASIA; HEART RIGHT VENTRICLE EJECTION FRACTION; HEART TRANSPLANTATION; HISTOPATHOLOGY; HUMAN; IMPLANTABLE CARDIOVERTER DEFIBRILLATOR; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVIEW; SODIUM CHANNELOPATHY; SUDDEN CARDIAC DEATH;

ARRHYTHMOGENIC RIGHT VENTRICULAR CARDIOMYOPATHY; BRUGADA SYNDROME; GENETICS; HETEROGENEITY; SODIUM CHANNEL; SUBSTRATE;

BRUGADA SYNDROME; ELECTROCARDIOGRAPHY; HUMANS; MYOCARDIUM; PHENOTYPE;

EID: 84897995302     PISSN: 10453873     EISSN: 15408167     Source Type: Journal    
DOI: 10.1111/jce.12366     Document Type: Review

References (50)

1. Brugada P, Brugada J,: Right bundle branch block, persistent ST segment elevation and sudden cardiac death: A distinct clinical and electrocardiographic syndrome. A multicenter report. J Am Coll Cardiol 1992; 20: 1391-1396.
2. Priori SG, Wilde AA, Horie M, Cho Y, Behr ER, Berul C, Blom N, Brugada J, Chiang CE, Huikuri H, Kannankeril P, Krahn A, Leenhardt A, Moss A, Schwartz PJ, Shimizu W, Tomaselli G, Tracy C,: Executive summary: HRS/EHRA/APHRS expert consensus statement on the diagnosis and management of patients with inherited primary arrhythmia syndromes. Heart Rhythm 2013; 10: e85-108.
3. Antzelevitch C, Brugada P, Borggrefe M, Brugada J, Brugada R, Corrado D, Gussak I, LeMarec H, Nademanee K, Perez Riera AR, Shimizu W, Schulze-Bahr E, Tan H, Wilde A,: Brugada syndrome: Report of the second consensus conference: Endorsed by the Heart Rhythm Society and the European Heart Rhythm Association. Circulation 2005; 111: 659-670.
4. Vohra J,: Diagnosis and management of Brugada syndrome. Heart, Lung Circ 2011; 20: 751-756.
5. Hoogendijk MG, Opthof T, Postema PG, Wilde AA, de Bakker JM, Coronel R,: The Brugada ECG pattern: A marker of channelopathy, structural heart disease, or neither? Toward a unifying mechanism of the Brugada syndrome. Circ Arrhythm Electrophysiol 2010; 3: 283-290.
6. Brugada P,: Commentary on the Brugada ECG pattern: A marker of channelopathy, structural heart disease, or neither? Toward a unifying mechanism of the Brugada syndrome. Circ Arrhythm Electrophysiol 2010; 3: 280-282.
7. Corrado D, Basso C, Buja G, Nava A, Rossi L, Thiene G,: Right bundle branch block, right precordial ST-segment elevation, and sudden death in young people. Circulation 2001; 103: 710-717.
8. Papavassiliu T, Wolpert C, Fluchter S, Schimpf R, Neff W, Haase KK, Duber C, Borggrefe M,: Magnetic resonance imaging findings in patients with Brugada syndrome. J Cardiovasc Electrophysiol 2004; 15: 1133-1138.
9. Catalano O, Antonaci S, Moro G, Mussida M, Frascaroli M, Baldi M, Cobelli F, Baiardi P, Nastoli J, Bloise R, Monteforte N, Napolitano C, Priori SG,: Magnetic resonance investigations in Brugada syndrome reveal unexpectedly high rate of structural abnormalities. Eur Heart J 2009; 30: 2241-2248.
10. Tessa C, Del Meglio J, Ghidini Ottonelli A, Diciotti S, Salvatori L, Magnacca M, Chioccioli M, Lera J, Vignali C, Casolo G,: Evaluation of Brugada syndrome by cardiac magnetic resonance. Int J Cardiovasc Imaging 2012; 28: 1961-1970.
11. Martini B, Nava A, Thiene G, Buja GF, Canciani B, Scognamiglio R, Daliento L, Dalla Volta S,: Ventricular fibrillation without apparent heart disease: Description of six cases. Am Heart J 1989; 118: 1203-1209.
12. Frustaci A, Priori SG, Pieroni M, Chimenti C, Napolitano C, Rivolta I, Sanna T, Bellocci F, Russo MA,: Cardiac histological substrate in patients with clinical phenotype of Brugada syndrome. Circulation 2005; 112: 3680-3687.
13. Zumhagen S, Spieker T, Rolinck J, Baba HA, Breithardt G, Bocker W, Eckardt L, Paul M, Wichter T, Schulze-Bahr E,: Absence of pathognomonic or inflammatory patterns in cardiac biopsies from patients with Brugada syndrome. Circ Arrhythm Electrophysiol 2009; 2: 16-23.
14. Ohkubo K, Watanabe I, Okumura Y, Takagi Y, Ashino S, Kofune M, Sugimura H, Nakai T, Kasamaki Y, Hirayama A, Morimoto S,: Right ventricular histological substrate and conduction delay in patients with Brugada syndrome. Int Heart J 2010; 51: 17-23.
15. van Veen TA, Stein M, Royer A, Le Quang K, Charpentier F, Colledge WH, Huang CL, Wilders R, Grace AA, Escande D, de Bakker JM, van Rijen HV,: Impaired impulse propagation in scn5a-knockout mice: Combined contribution of excitability, connexin expression, and tissue architecture in relation to aging. Circulation 2005; 112: 1927-1935.
16. Royer A, van Veen TA, Le Bouter S, Marionneau C, Griol-Charhbili V, Leoni AL, Steenman M, van Rijen HV, Demolombe S, Goddard CA, Richer C, Escoubet B, Jarry-Guichard T, Colledge WH, Gros D, de Bakker JM, Grace AA, Escande D, Charpentier F,: Mouse model of scn5a-linked hereditary Lenegre's disease: Age-related conduction slowing and myocardial fibrosis. Circulation 2005; 111: 1738-1746.
17. Plassart E, Reboul J, Rime CS, Recan D, Millasseau P, Eymard B, Pelletier J, Thomas C, Chapon F, Desnuelle C,: Mutations in the muscle sodium channel gene (scn4a) in 13 French families with hyperkalemic periodic paralysis and paramyotonia congenita: Phenotype to genotype correlations and demonstration of the predominance of two mutations. Eur J Hum Genet 1994; 2: 110-124.
18. Antzelevitch C,: The Brugada syndrome: Ionic basis and arrhythmia mechanisms. J Cardiovasc Electrophysiol 2001; 12: 268-272.
19. Bezzina CR, Barc J, Mizusawa Y, Remme CA, Gourraud JB, Simonet F, Verkerk AO, Schwartz PJ, Crotti L, Dagradi F, Guicheney P, Fressart V, Leenhardt A, Antzelevitch C, Bartkowiak S, Schulze-Bahr E, Zumhagen S, Behr ER, Bastiaenen R, Tfelt-Hansen J, Olesen MS, Kaab S, Beckmann BM, Weeke P, Watanabe H, Endo N, Minamino T, Horie M, Ohno S, Hasegawa K, Makita N, Nogami A, Shimizu W, Aiba T, Froguel P, Balkau B, Lantieri O, Torchio M, Wiese C, Weber D, Wolswinkel R, Coronel R, Boukens BJ, Bezieau S, Charpentier E, Chatel S, Despres A, Gros F, Kyndt F, Lecointe S, Lindenbaum P, Portero V, Violleau J, Gessler M, Tan HL, Roden DM, Christoffels VM, Le Marec H, Wilde AA, Probst V, Schott JJ, Dina C, Redon R,: Common variants at scn5a-scn10a and hey2 are associated with Brugada syndrome, a rare disease with high risk of sudden cardiac death. Nat Genet 2013; 45: 1044-1049.
20. Meregalli PG, Wilde AA, Tan HL,: Pathophysiological mechanisms of Brugada syndrome: Depolarization disorder, repolarization disorder, or more ? Cardiovasc Res 2005; 67: 367-378.
21. Nagase S, Kusano KF, Morita H, Fujimoto Y, Kakishita M, Nakamura K, Emori T, Matsubara H, Ohe T,: Epicardial electrogram of the right ventricular outflow tract in patients with the Brugada syndrome: Using the epicardial lead. J Am Coll Cardiol 2002; 39: 1992-1995.
22. Ohkubo K, Watanabe I, Takagi Y, Okumura Y, Ashino S, Kofune M, Kofune T, Shindo A, Sugimura H, Nakai T, Kunimoto S, Kasamaki Y, Saito S, Hirayama A,: Endocardial electrograms from the right ventricular outflow tract after induced ventricular fibrillation in patients with Brugada syndrome. Circ J 2007; 71: 1258-1262.
23. Shah AJ, Hocini M, Lamaison D, Sacher F, Derval N, Haissaguerre M,: Regional substrate ablation abolishes Brugada syndrome. J Cardiovasc Electrophysiol 2011; 22: 1290-1291.
24. Nademanee K, Veerakul G, Chandanamattha P, Chaothawee L, Ariyachaipanich A, Jirasirirojanakorn K, Likittanasombat K, Bhuripanyo K, Ngarmukos T,: Prevention of ventricular fibrillation episodes in Brugada syndrome by catheter ablation over the anterior right ventricular outflow tract epicardium. Circulation 2011; 123: 1270-1279.
25. Garcia FC, Bazan V, Zado ES, Ren JF, Marchlinski FE,: Epicardial substrate and outcome with epicardial ablation of ventricular tachycardia in arrhythmogenic right ventricular cardiomyopathy/dysplasia. Circulation 2009; 120: 366-375.
26. Watanabe H, Koopmann TT, Le Scouarnec S, Yang T, Ingram CR, Schott JJ, Demolombe S, Probst V, Anselme F, Escande D, Wiesfeld AC, Pfeufer A, Kaab S, Wichmann HE, Hasdemir C, Aizawa Y, Wilde AA, Roden DM, Bezzina CR,; Sodium channel beta1 subunit mutations associated with Brugada syndrome and cardiac conduction disease in humans. J Clin Invest 2008; 118: 2260-2268.
27. Hu D, Barajas-Martinez H, Burashnikov E, Springer M, Wu Y, Varro A, Pfeiffer R, Koopmann TT, Cordeiro JM, Guerchicoff A, Pollevick GD, Antzelevitch C,: A mutation in the beta 3 subunit of the cardiac sodium channel associated with Brugada ECG phenotype. Circ Cardiovasc Genet 2009; 2: 270-278.
28. Antzelevitch C, Pollevick GD, Cordeiro JM, Casis O, Sanguinetti MC, Aizawa Y, Guerchicoff A, Pfeiffer R, Oliva A, Wollnik B, Gelber P, Bonaros EP Jr, Burashnikov E, Wu Y, Sargent JD, Schickel S, Oberheiden R, Bhatia A, Hsu LF, Haissaguerre M, Schimpf R, Borggrefe M, Wolpert C,: Loss-of-function mutations in the cardiac calcium channel underlie a new clinical entity characterized by ST-segment elevation, short QT intervals, and sudden cardiac death. Circulation 2007; 115: 442-449.
29. Burashnikov E, Pfeiffer R, Barajas-Martinez H, Delpon E, Hu D, Desai M, Borggrefe M, Haissaguerre M, Kanter R, Pollevick GD, Guerchicoff A, Laino R, Marieb M, Nademanee K, Nam GB, Robles R, Schimpf R, Stapleton DD, Viskin S, Winters S, Wolpert C, Zimmern S, Veltmann C, Antzelevitch C,: Mutations in the cardiac l-type calcium channel associated with inherited j-wave syndromes and sudden cardiac death. Heart Rhythm 2010; 7: 1872-1882.
30. Barajas-Martinez H, Hu D, Ferrer T, Onetti CG, Wu Y, Burashnikov E, Boyle M, Surman T, Urrutia J, Veltmann C, Schimpf R, Borggrefe M, Wolpert C, Ibrahim BB, Sanchez-Chapula JA, Winters S, Haissaguerre M, Antzelevitch C,: Molecular genetic and functional association of brugada and early repolarization syndromes with s422l missense mutation in kcnj8. Heart Rhythm 2012; 9: 548-555.
31. Delpon EC, Nunez LJ, Thomsen P, Guerchicoff A, Pollevick G, Wu Y, Kanters J, Larsen C, Burashnikov E, Christiansen M, Antzelevitch C,: Functional effects of kcne3 mutation and its role in the development of Brugada syndrome. Circ Arrhythm Electrophysiol 2009; 1: 209-218.
32. Chen Q, Kirsch GE, Zhang D, Brugada R, Brugada J, Brugada P, Potenza D, Moya A, Borggrefe M, Breithardt G, Ortiz-Lopez R, Wang Z, Antzelevitch C, O'Brien RE, Schulze-Bahr E, Keating MT, Towbin JA, Wang Q,: Genetic basis and molecular mechanism for idiopathic ventricular fibrillation. Nature 1998; 392: 293-296.
33. Probst V, Veltmann C, Eckardt L, Meregalli PG, Gaita F, Tan HL, Babuty D, Sacher F, Giustetto C, Schulze-Bahr E, Borggrefe M, Haissaguerre M, Mabo P, Le Marec H, Wolpert C, Wilde AA,: Long-term prognosis of patients diagnosed with Brugada syndrome: Results from the finger Brugada syndrome registry. Circulation 2010; 121: 635-643.
34. Kapplinger JD, Tester DJ, Alders M, Benito B, Berthet M, Brugada J, Brugada P, Fressart V, Guerchicoff A, Harris-Kerr C, Kamakura S, Kyndt F, Koopmann TT, Miyamoto Y, Pfeiffer R, Pollevick GD, Probst V, Zumhagen S, Vatta M, Towbin JA, Shimizu W, Schulze-Bahr E, Antzelevitch C, Salisbury BA, Guicheney P, Wilde AA, Brugada R, Schott JJ, Ackerman MJ,: An international compendium of mutations in the scn5a-encoded cardiac sodium channel in patients referred for Brugada syndrome genetic testing. Heart Rhythm 2010; 7: 33-46.
35. Ackerman MJ, Priori SG, Willems S, Berul C, Brugada R, Calkins H, Camm AJ, Ellinor PT, Gollob M, Hamilton R, Hershberger RE, Judge DP, Le Marec H, McKenna WJ, Schulze-Bahr E, Semsarian C, Towbin JA, Watkins H, Wilde A, Wolpert C, Zipes DP,: HRS/EHRA expert consensus statement on the state of genetic testing for the channelopathies and cardiomyopathies this document was developed as a partnership between the Heart Rhythm Society (HRS) and the European Heart Rhythm Association (EHRA). Heart Rhythm 2011; 8: 1308-1339.
36. Probst V, Wilde AA, Barc J, Sacher F, Babuty D, Mabo P, Mansourati J, Le Scouarnec S, Kyndt F, Le Caignec C, Guicheney P, Gouas L, Albuisson J, Meregalli PG, Le Marec H, Tan HL, Schott JJ,. Scn5a mutations and the role of genetic background in the pathophysiology of Brugada syndrome. Circ Cardiovasc Genet 2009; 2: 552-557.
37. Brugada J, Brugada R, Antzelevitch C, Towbin J, Nademanee K, Brugada P,: Long-term follow-up of individuals with the electrocardiographic pattern of right bundle-branch block and ST-segment elevation in precordial leads v1 to v3. Circulation 2002; 105: 73-78.
38. Priori SG, Napolitano C, Gasparini M, Pappone C, Della Bella P, Giordano U, Bloise R, Giustetto C, De Nardis R, Grillo M, Ronchetti E, Faggiano G, Nastoli J,: Natural history of Brugada syndrome: Insights for risk stratification and management. Circulation 2002; 105: 1342-1347.
39. Wilde AA, Viskin S,. EP testing does not predict cardiac events in Brugada syndrome. Heart Rhythm 2011; 8: 1598-1600.
40. Priori SG, Gasparini M, Napolitano C, Della Bella P, Ottonelli AG, Sassone B, Giordano U, Pappone C, Mascioli G, Rossetti G, De Nardis R, Colombo M,: Risk stratification in Brugada syndrome: Results of the PRELUDE (programmed electrical stimulation predictive value) registry. J Am Coll Cardiol 2012; 59: 37-45.
41. Huang Z, Patel C, Li W, Xie Q, Wu R, Zhang L, Tang R, Wan X, Ma Y, Zhen W, Gao L, Yan GX,: Role of signal-averaged electrocardiograms in arrhythmic risk stratification of patients with brugada syndrome: A prospective study. Heart Rhythm 2009; 6: 1156-1162.
42. Sarkozy A, Chierchia GB, Paparella G, Boussy T, De Asmundis C, Roos M, Henkens S, Kaufman L, Buyl R, Brugada R, Brugada J, Brugada P,: Inferior and lateral electrocardiographic repolarization abnormalities in Brugada syndrome. Circ Arrhythm Electrophysiol 2009; 2: 154-161.
43. Kamakura S, Ohe T, Nakazawa K, Aizawa Y, Shimizu A, Horie M, Ogawa S, Okumura K, Tsuchihashi K, Sugi K, Makita N, Hagiwara N, Inoue H, Atarashi H, Aihara N, Shimizu W, Kurita T, Suyama K, Noda T, Satomi K, Okamura H, Tomoike H,: Long-term prognosis of probands with Brugada-pattern ST-elevation in leads v1-v3. Circ Arrhythm Electrophysiol 2009; 2: 495-503.
44. Kawata H, Morita H, Yamada Y, Noda T, Satomi K, Aiba T, Isobe M, Nagase S, Nakamura K, Fukushima Kusano K, Ito H, Kamakura S, Shimizu W,: Prognostic significance of early repolarization in inferolateral leads in Brugada patients with documented ventricular fibrillation: A novel risk factor for Brugada syndrome with ventricular fibrillation. Heart Rhythm 2013; 10: 1161-1168.
45. Rollin A, Sacher F, Gourraud JB, Pasquie JL, Raczka F, Duparc A, Mondoly P, Cardin C, Delay M, Chatel S, Derval N, Denis A, Sadron M, Davy JM, Hocini M, Jais P, Jesel L, Haissaguerre M, Probst V, Maury P,: Prevalence, characteristics, and prognosis role of type 1 ST elevation in the peripheral ECG leads in patients with Brugada syndrome. Heart Rhythm 2013; 10: 1012-1018.
46. Viskin S, Adler A, Rosso R,: Brugada burden in Brugada syndrome: The way to go in risk stratification? Heart Rhythm 2013; 10: 1019-1020.
47. Extramiana F, Maison-Blanche P, Badilini F, Messali A, Denjoy I, Leenhardt A,: Type 1 electrocardiographic burden is increased in symptomatic patients with Brugada syndrome. J Electrocardiol 2010; 43: 408-414.
48. Hermida JS, Denjoy I, Clerc J, Extramiana F, Jarry G, Milliez P, Guicheney P, Di Fusco S, Rey JL, Cauchemez B, Leenhardt A,: Hydroquinidine therapy in Brugada syndrome. J Am Coll Cardiol 2004; 43: 1853-1860.
49. Viskin S, Wilde AA, Tan HL, Antzelevitch C, Shimizu W, Belhassen B,: Empiric quinidine therapy for asymptomatic Brugada syndrome: Time for a prospective registry. Heart Rhythm 2009; 6: 401-404.
50. Ohgo T, Okamura H, Noda T, Satomi K, Suyama K, Kurita T, Aihara N, Kamakura S, Ohe T, Shimizu W,: Acute and chronic management in patients with Brugada syndrome associated with electrical storm of ventricular fibrillation. Heart Rhythm 2007; 4: 695-700.